Robert Iannone - Net Worth and Insider Trading

Robert Iannone Net Worth

The estimated net worth of Robert Iannone is at least $16 Million dollars as of 2026-09-12. Robert Iannone is the EVP, Global Head of R&D & CMO of Jazz Pharmaceuticals PLC and owns about 65,686 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $16 Million. Details can be seen in Robert Iannone's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Iannone has not made any transactions after 2026-08-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Robert Iannone

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Robert Iannone Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Iannone owns 6 companies in total, including Jounce Therapeutics Inc (JNCE) , Jazz Pharmaceuticals PLC (JAZZ) , and Immunomedics Inc (IMMU) among others .

Click here to see the complete history of Robert Iannone’s form 4 insider trades.

Insider Ownership Summary of Robert Iannone

Ticker Company Transaction Date Type of Owner
JNCE Jounce Therapeutics Inc 2020-01-21 director
JAZZ Jazz Pharmaceuticals PLC 2026-08-27 EVP & Global Head of R&D & CMO
IMMU Immunomedics Inc 2019-03-14 CHIEF MEDICAL OFFICER
LIMIT LIMIT 2021-04-29 director
LIMIT LIMIT 2026-03-18 director
LIMIT LIMIT 2026-07-09 director

Robert Iannone Latest Holdings Summary

Robert Iannone currently owns a total of 1 stock. Robert Iannone owns 65,686 shares of Jazz Pharmaceuticals PLC (JAZZ) as of August 27, 2026, with a value of $16 Million.

Latest Holdings of Robert Iannone

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
JAZZ Jazz Pharmaceuticals PLC 2026-08-27 65,686 245.85 16,148,903

Holding Weightings of Robert Iannone


Robert Iannone Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Iannone has made a total of 5 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 76,921 shares on August 27, 2026, which brought Robert Iannone around $19 Million.

Insider Trading History of Robert Iannone

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Iannone Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Robert Iannone owns.
View JAZZ Analysis

Robert Iannone Ownership Network

Ownership Network List of Robert Iannone

No Data

Ownership Network Relation of Robert Iannone

Insider Network Chart


Robert Iannone Owned Company Details

What does Jounce Therapeutics Inc do?

Who are the key executives at Jounce Therapeutics Inc?

Robert Iannone is the director of Jounce Therapeutics Inc. Other key executives at Jounce Therapeutics Inc include 10 percent owner Concentra Merger Sub, Inc. , 10 percent owner Concentra Biosciences, Llc , and director & CEO and President Richard /ca/ Murray .

Jounce Therapeutics Inc (JNCE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Jounce Therapeutics Inc (JNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jounce Therapeutics Inc (JNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Jounce Therapeutics Inc (JNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jounce Therapeutics Inc Insider Transactions

No Available Data

Robert Iannone Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Iannone. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Robert Iannone's mailing address is: Palo Alto Ca 94304.